These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27570154)

  • 21. Obesity medications: what does the future look like?
    Butsch WS
    Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):360-6. PubMed ID: 26313898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The gut yields clues to obesity, therapies.
    Kuehn BM
    JAMA; 2005 May; 293(18):2200-1. PubMed ID: 15886364
    [No Abstract]   [Full Text] [Related]  

  • 23. A risk-benefit assessment of anti-obesity drugs.
    Kolanowski J
    Drug Saf; 1999 Feb; 20(2):119-31. PubMed ID: 10082070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central and peripheral neuroendocrine peptides and signalling in appetite regulation: considerations for obesity pharmacotherapy.
    Atkinson TJ
    Obes Rev; 2008 Mar; 9(2):108-20. PubMed ID: 18257752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid receptor antagonists and obesity.
    Black SC
    Curr Opin Investig Drugs; 2004 Apr; 5(4):389-94. PubMed ID: 15134279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update in the management of obesity: the weight of CNS targets.
    Bariohay B; Roux JA; Bonnet MS; Dallaporta M; Troadec JD
    Recent Pat CNS Drug Discov; 2011 Sep; 6(3):164-80. PubMed ID: 21834783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targets for medical therapy in obesity.
    Baretić M
    Dig Dis; 2012; 30(2):168-72. PubMed ID: 22722433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-hypertensive treatment preserves appetite suppression while preventing cardiovascular adverse effects of tesofensine in rats.
    Bentzen BH; Grunnet M; Hyveled-Nielsen L; Sundgreen C; Lassen JB; Hansen HH
    Obesity (Silver Spring); 2013 May; 21(5):985-92. PubMed ID: 23784901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity drug pipeline not so fat.
    Gura T
    Science; 2003 Feb; 299(5608):849-52. PubMed ID: 12574616
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacologic management of obesity.
    Kushner RF
    Pediatr Blood Cancer; 2012 Jan; 58(1):140-3. PubMed ID: 22009632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiobesity effects of melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
    Cheon HG
    Handb Exp Pharmacol; 2012; (209):383-403. PubMed ID: 22249825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of acute low-dose combined treatment with rimonabant and sibutramine on appetite and weight gain in rats.
    Tallett AJ; Blundell JE; Rodgers RJ
    Pharmacol Biochem Behav; 2010 Nov; 97(1):92-100. PubMed ID: 20026165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging drugs for the treatment of obesity.
    Martinussen C; Bojsen-Moller KN; Svane MS; Dejgaard TF; Madsbad S
    Expert Opin Emerg Drugs; 2017 Mar; 22(1):87-99. PubMed ID: 27927032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy of obesity: an update.
    Schurgin S; Siegel RD
    Nutr Clin Care; 2003; 6(1):27-37. PubMed ID: 12841428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the Effects and Mechanism of L-Citrulline on Anti-obesity by Appetite Suppression in Obese/Diabetic KK-Ay Mice and High-Fat Diet Fed SD Rats.
    Kudo M; Yoshitomi H; Momoo M; Suguro S; Yamagishi Y; Gao M
    Biol Pharm Bull; 2017; 40(4):524-530. PubMed ID: 28381807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy for obesity.
    Ioannides-Demos LL; Proietto J; McNeil JJ
    Drugs; 2005; 65(10):1391-418. PubMed ID: 15977970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current pharmacotherapy for obesity.
    Srivastava G; Apovian CM
    Nat Rev Endocrinol; 2018 Jan; 14(1):12-24. PubMed ID: 29027993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic therapies for obesity.
    Kaplan LM
    Gastroenterol Clin North Am; 2010 Mar; 39(1):69-79. PubMed ID: 20202580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of Obesity and Pharmacologic Treatment Options.
    Shettar V; Patel S; Kidambi S
    Nutr Clin Pract; 2017 Aug; 32(4):441-462. PubMed ID: 28632997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.